Navigation Links
Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants
Date:7/23/2008

HACKENSACK, N.J., July 16 /PRNewswire/ --- Over the past two decades, stem cell transplantation has evolved from being an experimental treatment to one that is a viable option for patients with hematologic (blood) malignancies and other life-threatening blood disorders. Researchers and clinicians at the Adult Blood and Marrow Stem Cell Transplantation Program at The Cancer Center at Hackensack University Medical Center are responsible for many of the innovations and techniques used in today's successful transplants.

Stem cell transplantation researchers in The Cancer Center's Division of Research recently published results of a study in Blood, the scientific journal of the American Society of Hematology, that may take physicians one step closer to performing customized "designer" stem cell transplants that could lead to better treatment outcomes for patients.

The paper, "Overlap Between in vitro Donor Anti-Host and in vivo Post Transplantation T Cell Response Vß Utilization: A New Paradigm for Designer Allogeneic Blood and Marrow Transplantation," was co-authored by Cancer Center researchers Thea Friedman, Ph.D., director of laboratory research; Robert Korngold, Ph.D., chief of the Division of Research; Michele L. Donato, M.D., director of the Blood and Marrow Collection Facility; and Scott D. Rowley, M.D., chief of the Division of Blood and Marrow Stem Cell Transplantation; and researchers from the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia. The paper confirms that a technique - called Vß (beta) spectratype analysis - can be used to identify mature donor T cells (disease-fighting white blood cells) that can be harmful to the patient.

One of the major risks of an allogeneic transplant (one that uses stem cells removed from a donor) is graft-versus-host disease (GVHD). GVHD is a potentially fatal complication that can occur when mature donor T cells that are transferred along with stem cells from donated blood or b
'/>"/>

SOURCE The Cancer Center
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkins Lymphoma
2. DARPA awards research team $1.2M grant to study surface enhanced Raman scattering
3. Argonne researchers win 2 R&D 100 Awards
4. AMT Starts Collaboration With St. Jude Childrens Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
5. Worldwide Clinical Trials Emerges as Leading Global Contract Research Organization
6. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
7. Research helps understand factors that influence efficiency of organic-based devices
8. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
9. Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2008 Winners Announced
10. Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties
11. Albany College of Pharmacy Researcher Receives $368,445 Grant from the National Institutes of Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...-Asia/--NODPharmaceuticalsInc.announced,theUSPaten...cationfor,itsnano-particleoraldeliveryorNODtechnol...htoincorporatepeptidesor,proteinsintobio-adhesiven...administeredasinjections.NODtechnologyisaplatformt...ssuchasinsulin,interferon,growthhormone,exenatide...
(Date:11/24/2009)...recently approved the Promega PowerPlex 16 HS Syst...erating DNA records for the National DNA Index Sys...RWEB) -- The FBI recently approved the Promega Po... participating in, or generating DNA records for, ...ly contains more than seven million profiles and h...
(Date:11/24/2009)...swire-FirstCall/--ArenaPharmaceuticals,Inc.(Nasdaq...opresentatthePiperJaffray21stAnnualHealthCareConfe...m.PacificTime)attheNewYorkPalaceHotelinNewYorkCity...er,isscheduledtoprovideanoverviewofthecompany,incl..., Aliveaudiowebcastofthepresentationwillbeavail...
(Date:11/24/2009)... Abstracts Service (CAS), the global expert on che...ice is now the world,s leading producer of patent ... Japan,s patent office, the World Intellectual Pro...atent and Trademark Office (USPTO) for more than a...6, and exceeded Japan for the first time on a mont...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...ire-FirstCall/ - Dragon Pharmaceutical Inc. ("Drag... BBSE: DRP), a leading international pharmaceutica...been set as the date for the Annual Stockholders, ...rs will be held at Hyatt Regency Hong Kong, Sha Ti..., Hong Kong, P.R. China at 10:30 am local time. St...
...e-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), ...eins and oils in plant seeds, today reported encou...lopment program. Results from recent preclinical s...ilano) has exhibited the appropriate biological ac...aque volume. , New data from two of the largest an...
...swire-Asia/ -- Leading pharmaceutical and biotech,...twork of public-sector and,academic institutes to ...mic,insights and diversify risks. Located at the h...entative of key Asian ethnic groups, Singapore pro...est and develop new solutions for,Asia and beyond....
Other Biology Technology:SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 2SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 3SemBioSys' plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models 4Pharma and Biotech Companies Plug into Singapore's Integrated Research Network 2Pharma and Biotech Companies Plug into Singapore's Integrated Research Network 3Pharma and Biotech Companies Plug into Singapore's Integrated Research Network 4Pharma and Biotech Companies Plug into Singapore's Integrated Research Network 5
(Date:11/25/2009)...rs and ambulance workers faced a terrifying rescue...ttled to save people from the collapsing Twin Towe...uated as many people as they could in an area whic... their jobs even harder was the problem of poor co...es jammed mobile networks with calls and the emerg...
(Date:11/25/2009)...tal to your health as what you eat, found research...Their experiments in mice revealed that the daily ...erthe body,s metabolic clearinghouseis mostly cont...ian clock as conventional wisdom had it. , "If ...mber of genes completely independent of the circad...
(Date:11/24/2009)...s from collapsing have been true life-savers. But ...d -- once the arteries are strengthened, they beco...but to leave them in place. , Prof. Meital Zilbe...ical Engineering has developed a new patent-pendin...needed, then dissolves. , "Our new composite fib...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2Deputy Secretary Gould Talks Strategies for Federal Performance 58901 1Deputy Secretary Gould Talks Strategies for Federal Performance 58901 2Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 1Hugh Chatham Adopts Star Trek Technology with the Use of Palm Identify to Prevent Medical ID Theft 58898 2YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 1YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 2YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 3YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 4YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 5YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 6
...iversity of North Carolina at Chapel Hill have pur...gene activity by reversing a molecular modificatio...e authors showed that a protein called JHDM1A is a...of four histone proteins bound to all genes. Until... a histone had been regarded as irreversible. , "...
...iversities of Heidelberg and Ulm and a unit of the...onterotondo, Italy, have discovered that a specifi...they live or die after a stroke. Their study, publ...ongly suggests that new therapies for victims of s...e involved in passing the signal. , Strokes lead t...
...rs have found Envisat,s MERIS sensor can detect co...Envisat could potentially monitor impacted coral r...eaching happens when symbiotic algae living in sym...m their distinctive colours) are expelled. The whi...e reef ecosystem, and thus fisheries, regional tou...
Other Biology News:Novel enzyme offers new look at gene regulation 2Limiting the damage in stroke 2Limiting the damage in stroke 3Health of coral reefs detected from orbit 2
...n Kit, 500 reactions. Prepare circular DNA templat...m quantities of template DNA from picogram amounts...or cycle sequencing without purification.Amplify D..., plaques, or purified circular (plasmid or M13) D...
Microplate Rack for Standard Plates from Thermo Scientific
Beacon 2000 Test Tubes,10x75mm from Invitrogen
Microplate Genie from Femto Scientific
Biology Products: